Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Annals of Surgery|May 1, 1994
A bioartificial liver to treat severe acute liver failureJ Rozga, L Podesta, E LePage, et al.
Cancer|August 16, 2001
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trialP Brice, P Colin, F Berger, et al.
Blood|November 14, 1997
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcomeH Tilly, P Gaulard, E Lepage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphomaC Haioun, E Lepage, C Gisselbrecht, et al.
The Journal of Reproductive Medicine|November 1, 1986
Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placeboD Brown, M R Henzl, M E LePage, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Early clinical experience with a hybrid bioartificial liverA A Demetriou, J Rozga, L Podesta, et al.
Cancer|May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'AdulteN Mounier, P Morel, C Haioun, et al.
Annales Francaises D'Anesthesie Et De Reanimation|February 26, 2004
[Completeness of ICU activity reports sent to French healthcare authorities]P Moine, F Hémery, J P Blériot, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patientsC Fermé, E Lepage, P Brice, et al.
The European Respiratory Journal|February 1, 1992
The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomasJ Tredaniel, P Brice, E Lepage, et al.
Pageof 12